Cutaneous infection due to Mycobacterium chelonae during anti-TNF therapy;Infection cutanée à Mycobacterium chelonae au cours d'un traitement par anti-TNF

Annales de Dermatologie et de Venereologie

Volumn 136, Issue 11, 2009, Pages 811-814

  Adenis Lamarre, E ^a   Kostrzewa, E ^a   Texier Maugein, J ^a   Doutre, M S ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Adalimumab; Anti TNF therapy; Cutaneous infection; Etanercept; Mycobacterium chelonae

Indexed keywords

ADALIMUMAB; AMOXICILLIN PLUS CLAVULANIC ACID; ETANERCEPT; METHOTREXATE; PREDNISONE; TIGACYL; TIGECYCLINE; UNCLASSIFIED DRUG;

AGED; ANAMNESIS; ARTICLE; BACTERIUM CULTURE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MYCOBACTERIOSIS; MYCOBACTERIUM CHELONEI; OUTCOME ASSESSMENT; RHEUMATOID ARTHRITIS; SKIN INFECTION; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; BIOPSY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, ATYPICAL; PREDNISONE; RECEPTORS, TUMOR NECROSIS FACTOR; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70749121374     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2009.09.008     Document Type: Article

References (18)

1. J.A. Jarzembowski, and M.B. Young Nontuberculous mycobacterial infections Arch Pathol Lab Med 132 2008 1333 1341
2. M.A. Gardam, E.C. Keystone, R. Menzies, S. Manners, E. Skamene, R. Long, et al. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management Lancet Infect Dis 3 2003 148 155
3. R.S. Wallis, M.S. Broder, J.Y. Wong, M.E. Hanson, and D.O. Beenhouwer Granulomatous infectious diseases associated with tumor necrosis factor antagonists Clin Infect Dis 38 2004 1261 1265
4. S. Ehlers Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept? Clin Infect Dis 41 2005 S199 203
5. O.Y. Saliu, C. Sofer, D.S. Stein, S.K. Schwander, and R.S. Wallis Tumor necrosis factor blockers: differential effects on mycobacterial immunity J Infect Dis 194 2006 486 492
6. J.M. Shehan, and D.P. Sarma Mycobacterium mucogenicum: report of a skin infection associated with etanercept Dermatol Online J 14 2008 5
7. E. Rallis, E. Koumantiaki-Mathoudaki, E. Frangoulis, E. Chatziolou, and A. Katsambas Severe sporotrichoid fish tank granuloma following infliximab therapy Am J Clin Dermatol 8 2007 385 388
8. P. Del Giudice, C. Roux, V. Blanc-Amrane, O. Brock, L. Euler-Ziegler, and J. Durant Infection cutanée à Mycobacterium marinum au cours d'un traitement par infliximab Ann Dermatol Venereol 135 2008 A217 [abstract]
9. C. Sorensen, A. Billet, A. Dabdan, F. Dhaille, and C. Lok Infection à Mycobacterium marinum chez une patiente traitée par infliximab pour une maladie de Crohn Ann Dermatol Venereol 135 2008 A219 A220 [abstract]
10. J.C. Fallon, S. Patchett, C. Gulmann, and G.M. Murphy Mycobacterium marinum infection complicating Crohn's disease, treated with infliximab Clin Exp Dermatol 33 2008 43 45
11. J.R. Danko, W.R. Gilliland, R.S. Miller, and C.F. Decker Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy Scand J Infect Dis 41 2009 252 255
12. Guyot A, Begon E, Abramowitz L, Landry J, Marinho E, Descamps V, et al. Infection cutanée à Mycobacterium marinum chez un patient traité par infliximab pour une maladie de Crohn. Ann Dermatol Venereol.
13. A.H. Mufti, B.W. Toye, R.R. Mckendry, and J.B. Angel Mycobacterium abscessus infection after use of tumor necrosis factor alpha inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor alpha inhibitor use Diagn Microbiol Infect Dis 53 2005 233 238
14. N. Sicot, J.B. Gaultier, P. Parize, M. Puget, and H. Rousset Infection cutanée disséminée à Mycobacterium chelonae mimant une poussée de vascularite Rev Med Int 27 2006 S387 S388 [abstract]
15. F. Diaz, J.C. Urkijo, F. Mendoza, J.M. De la Viuda, M. Blanco, A. Unzurrunzaga, et al. Mycobacterium chelonae infection associated with adalimumab therapy Scand J Rheumatol 37 2008 159 160
16. F. Camou, M. Beylot-Barry, I. Noblesse, J. Texier-Maugein, M.S. Doutre, and C. Beylot Infections à Mycobacterium chelonae et M. abscessus. Revue à propos d'un cas d'infection cutanée à M. chelonae Med Mal Infect 33 2003 169 171
17. R.J. Wallace Jr., B.A. Brown-Elliott, S.C. Ward, C.J. Crist, L.B. Mann, and R.W. Wilson Activities of linezolid against rapidly growing mycobacteria Antimicrob Agents Chemother 45 2001 764 767
18. R.J. Wallace, B.A. Brown-Elliott, C.J. Crist, L. Mann, and R.W. Wilson Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria Antimicrob Agents Chemother 46 2002 3164 3167